NEUROCRINE BIOSCIENCES INC (1NBIX.MI) Stock Earnings Estimates
Europe • Euronext Milan • BIT:1NBIX • US64125C1099
131.55 EUR
+6.15 (+4.9%)
Last: Dec 22, 2025, 07:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.489B 31.34% | 1.887B 26.76% | 2.355B 24.81% | 2.913B 23.68% | 3.451B 18.47% | 3.762B 9.01% | 4.154B 10.42% | 4.305B 3.64% | 4.771B 10.82% | 5.267B 10.40% | 5.673B 7.71% | |
| EBITDA YoY % growth | 266.3M 21.76% | 416.1M 56.25% | 610.1M 46.62% | 657.81M 7.82% | 824.99M 25.41% | 1.076B 30.43% | 1.314B 22.12% | 1.506B 14.61% | 1.96B 30.15% | 2.739B 39.74% | 3.535B 29.06% | |
| EBIT YoY % growth | 250.7M 20.64% | 394.8M 57.48% | 583M 47.67% | 676.19M 15.98% | 943.59M 39.55% | 1.172B 24.21% | 1.427B 21.76% | 1.504B 5.40% | 1.953B 29.85% | 2.652B 35.79% | 3.003B 13.24% | |
| Operating Margin | 16.84% | 20.92% | 24.75% | 23.21% | 27.34% | 31.15% | 34.35% | 34.94% | 40.93% | 50.35% | 52.93% | |
| EPS YoY % growth | 1.53 15.91% | 2.42 58.17% | 3.29 35.95% | 5.13 55.94% | 7.20 40.43% | 8.64 19.91% | 13.84 60.15% | 14.78 6.83% | 17.09 15.64% | 17.80 4.14% | 18.97 6.56% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.94 94.42% | 1.48 1,751.07% | 1.75 65.25% | 1.89 -7.27% | 2.04 5.12% |
| Revenue Q2Q % growth | 821.66M 30.90% | 794.07M 38.68% | 853.91M 24.21% | 891.09M 12.10% | 927.66M 12.90% |
| EBITDA Q2Q % growth | 264.39M 53.63% | 207.54M 563.07% | 204.9M 27.66% | 217.2M -17.07% | 139.63M -47.19% |
| EBIT Q2Q % growth | 241.17M 66.32% | 181.98M 667.85% | 216.86M 48.94% | 248.22M 3.73% | 291.11M 20.71% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 2.04 64.52% | 1.62 | 0.42 | 26.10% |
| Q2 2025 Q2Q % growth | 1.06 68.25% | 0.99 | 0.07 | 7.00% |
| Q1 2025 Q2Q % growth | 0.08 -80.95% | 0.56 | -0.48 | -85.62% |
| Q4 2024 Q2Q % growth | 1.00 -30.56% | 1.59 | -0.59 | -37.18% |
| Q3 2024 Q2Q % growth | 1.24 51.22% | 1.50 | -0.26 | -17.35% |
| Q2 2024 Q2Q % growth | 0.63 -33.68% | 1.08 | -0.45 | -41.42% |
| Q1 2024 Q2Q % growth | 0.42 153.16% | 1.03 | -0.61 | -59.17% |
| Q4 2023 Q2Q % growth | 1.44 63.64% | 1.17 | 0.27 | 23.28% |
| Q3 2023 Q2Q % growth | 0.82 18.84% | 0.99 | -0.17 | -16.79% |
| Q2 2023 Q2Q % growth | 0.95 627.78% | 0.79 | 0.16 | 19.84% |
| Q1 2023 Q2Q % growth | -0.79 -664.29% | 0.13 | -0.92 | -697.25% |
| Q4 2022 Q2Q % growth | 0.88 1,200.00% | 1.18 | -0.30 | -25.33% |
| Q3 2022 Q2Q % growth | 0.69 7.81% | 0.81 | -0.12 | -14.90% |
| Q2 2022 Q2Q % growth | -0.18 -141.86% | 0.61 | -0.79 | -129.58% |
| Q1 2022 Q2Q % growth | 0.14 -57.58% | 0.36 | -0.22 | -60.95% |
| Q4 2021 Q2Q % growth | -0.08 -111.11% | 0.53 | -0.61 | -115.18% |
| Q3 2021 Q2Q % growth | 0.64 203.23% | 0.62 | 0.02 | 3.97% |
| Q2 2021 Q2Q % growth | 0.43 -46.91% | 0.49 | -0.06 | -12.38% |
| Q1 2021 Q2Q % growth | 0.33 -15.38% | 0.52 | -0.19 | -36.84% |
| Q4 2020 Q2Q % growth | 0.72 | 0.55 | 0.17 | 31.63% |
| Q3 2020 Q2Q % growth | -0.62 | 0.17 | -0.79 | -456.57% |
| Q2 2020 Q2Q % growth | 0.81 | 0.75 | 0.06 | 8.08% |
| Q1 2020 Q2Q % growth | 0.39 | 0.55 | -0.16 | -29.31% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 794.9M 27.78% | 761.45M | 33.45M | 4.39% |
| Q2 2025 Q2Q % growth | 687.5M 16.49% | 665.66M | 21.84M | 3.28% |
| Q1 2025 Q2Q % growth | 572.6M 11.12% | 573.41M | -810K | -0.14% |
| Q4 2024 Q2Q % growth | 627.7M 21.84% | 641.57M | -13.87M | -2.16% |
| Q3 2024 Q2Q % growth | 622.1M 24.72% | 612.64M | 9.46M | 1.54% |
| Q2 2024 Q2Q % growth | 590.2M 30.37% | 556.86M | 33.34M | 5.99% |
| Q1 2024 Q2Q % growth | 515.3M 22.57% | 522.21M | -6.91M | -1.32% |
| Q4 2023 Q2Q % growth | 515.2M 25.05% | 528.84M | -13.64M | -2.58% |
| Q3 2023 Q2Q % growth | 498.8M 28.59% | 479.9M | 18.9M | 3.94% |
| Q2 2023 Q2Q % growth | 452.7M 19.70% | 456.25M | -3.55M | -0.78% |
| Q1 2023 Q2Q % growth | 420.4M 35.35% | 417.45M | 2.95M | 0.71% |
| Q4 2022 Q2Q % growth | 412M 32.05% | 417.05M | -5.05M | -1.21% |
| Q3 2022 Q2Q % growth | 387.9M 31.05% | 384.51M | 3.39M | 0.88% |
| Q2 2022 Q2Q % growth | 378.2M 30.91% | 348.13M | 30.07M | 8.64% |
| Q1 2022 Q2Q % growth | 310.6M 31.28% | 310.27M | 330K | 0.11% |
| Q4 2021 Q2Q % growth | 312M 25.86% | 323.85M | -11.85M | -3.66% |
| Q3 2021 Q2Q % growth | 296M 14.51% | 303.75M | -7.75M | -2.55% |
| Q2 2021 Q2Q % growth | 288.9M -4.46% | 279M | 9.9M | 3.55% |
| Q1 2021 Q2Q % growth | 236.6M -0.21% | 255.65M | -19.05M | -7.45% |
| Q4 2020 Q2Q % growth | 247.9M | 266.32M | -18.42M | -6.92% |
| Q3 2020 Q2Q % growth | 258.5M | 288.7M | -30.2M | -10.46% |
| Q2 2020 Q2Q % growth | 302.4M | 265.73M | 36.67M | 13.80% |
| Q1 2020 Q2Q % growth | 237.1M | 228.35M | 8.75M | 3.83% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.56% | N/A | 1.62% | N/A |
| Revenue | -0.05% | N/A | 0% | N/A |